Weill Cornell Medicine Englander Institute for Precision Medicine

09/04/2026

Join us today at noon for the Meyer Cancer Center Genetics & Epigenetics Research Program talk by EIPM's Dr. Niroshana Anandasabapathy!

Join us Friday for the Meyer Cancer Center Genetics & Epigenetics Research Program talk by EIPM's Dr. Niroshana Anandasabapathy!

09/03/2026

Our next EIPM Journal Club will feature Dr. Eda Nur Kozan from WCM's Dept. of Pathology and Laboratory Medicine presenting a paper on on Sept. 24th at 3 PM.

We hope you can join us!

09/02/2026

Join us Friday for the Meyer Cancer Center Genetics & Epigenetics Research Program talk by EIPM's Dr. Niroshana Anandasabapathy!

09/02/2026

Don't miss our next Precision Medicine Seminar featuring talks by Drs. Stefano Cirigliano and Benjamin Hopkins!

09/02/2026

We hope you can join us for a Precision Medicine Research Conference presentation by our Chief Research Officer Bishoy Faltas M.D. next Thursday!

08/31/2026

“This is one step toward our goal, which is not to design a drug that is supposed to work for a million patients or a thousand patients, but to design one that is customized to one unique patient,” said EIPM's Olivier Elemento, Ph.D. on his Nature Communications paper.

A team of Weill Cornell Medicine investigators has developed a computer model that will help scientists more efficiently develop protein-destroying therapies, a newer type of treatment that is particularly promising for cancer. The studywas published July 13 in Nature Communications.

08/31/2026

“This is one step toward our goal, which is not to design a drug that is supposed to work for a million patients or a thousand patients, but to design one that is customized to one unique patient,” said EIPM Director Olivier Elemento, Ph.D. on his recent paper in Nature Communications.

A team of Weill Cornell Medicine investigators has developed a computer model that will help scientists more efficiently develop protein-destroying therapies, a newer type of treatment that is particularly promising for cancer. The studywas published July 13 in Nature Communications.

08/26/2026

Interested in medical ethics and AI? If so, be sure to check out "A Conversational Ethics Bot (CALEB) Versus GPT-4o for Medical Ethics Education: Transcript Analysis and Extended Reality Feasibility Study," a new paper in the Journal of Medical Extended Reality by our EIPM colleagues Alex Sigaras and Sandhya Sriram!

https://journals.sagepub.com/doi/10.1177/29941520261469342

08/24/2026

Congratulations to our EIPM colleague Dr. Dan Landau () on being named Inaugural Chair of the Department of Systems and Computational Biomedicine ! !

The new department will be a catalyst for collaborative research at Weill Cornell Medicine, integrating advanced genomics and patient-focused technologies that generate large and complex datasets with computational approaches—including artificial intelligence—that allow researchers to gain unpre...

08/24/2026

Check out "Role of orphan G protein-coupled receptor in cell multicellular organization and collective invasion," in the latest edition of the British Journal of Cancer () by our EIPM Director Olivier Elemento, PhD (), Bhavneet Bhinder, MS () & colleagues!

G protein-coupled receptors (GPCRs) are the largest class of membrane-bound receptors and are emerging as targets for the effective treatment of cancer. The role of orphan GPCR GPR52 in cancer has not been characterized. Low mRNA expression of GPR52 in breast tumours correlates with reduced overall....